Hvsen Biotechnology Co., Ltd. (300871.SZ)
CNY 11.77
(-0.17%)
CNY 11.77
(-0.17%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.97 Billion CNY | -0.46% |
| 2022 | 2.98 Billion CNY | 9.03% |
| 2021 | 2.74 Billion CNY | 56.47% |
| 2020 | 1.75 Billion CNY | 169.54% |
| 2019 | 650.08 Million CNY | 39.32% |
| 2018 | 466.59 Million CNY | 35.57% |
| 2017 | 344.17 Million CNY | 34.52% |
| 2016 | 255.85 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 2.91 Billion CNY | -0.97% |
| 2024 Q1 | 2.99 Billion CNY | 0.62% |
| 2024 Q2 | 2.94 Billion CNY | -1.76% |
| 2023 Q1 | 3.02 Billion CNY | 1.18% |
| 2023 FY | 2.97 Billion CNY | -0.46% |
| 2023 Q4 | 2.97 Billion CNY | 2.21% |
| 2023 Q3 | 2.91 Billion CNY | -2.17% |
| 2023 Q2 | 2.97 Billion CNY | -1.62% |
| 2022 Q4 | 2.98 Billion CNY | 7.88% |
| 2022 Q3 | 2.77 Billion CNY | 3.33% |
| 2022 Q2 | 2.68 Billion CNY | -0.73% |
| 2022 Q1 | 2.7 Billion CNY | -1.47% |
| 2022 FY | 2.98 Billion CNY | 9.03% |
| 2021 Q2 | 1.87 Billion CNY | 5.0% |
| 2021 Q1 | 1.78 Billion CNY | 2.06% |
| 2021 Q3 | 1.97 Billion CNY | 5.17% |
| 2021 Q4 | 2.74 Billion CNY | 38.82% |
| 2021 FY | 2.74 Billion CNY | 56.47% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 1.75 Billion CNY | 169.54% |
| 2020 Q4 | 1.75 Billion CNY | -0.52% |
| 2020 Q3 | 1.76 Billion CNY | 116.84% |
| 2020 Q2 | 812.25 Million CNY | 0.0% |
| 2019 Q2 | 541.19 Million CNY | 0.0% |
| 2019 Q4 | 650.08 Million CNY | 0.0% |
| 2019 FY | 650.08 Million CNY | 39.32% |
| 2018 FY | 466.59 Million CNY | 35.57% |
| 2017 FY | 344.17 Million CNY | 34.52% |
| 2016 FY | 255.85 Million CNY | 0.0% |